Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.25 TWD
136.73 M TWD
123.13 M TWD
424.38 M
About TAIGEN BIOPHARMACEUTICALS HLDGS LTD
Sector
Industry
CEO
Kuo Long Huang
Website
Headquarters
Taipei
Founded
2001
FIGI
BBG0055NWZ45
TaiGen Biopharmaceuticals Holdings Ltd. engages in the development of novel therapeutics for infectious diseases, cancer, and diabetes-related complications. Its products include treatment fordrug-resistant bacterial infections Nemonoxacin, stem cell mobilizer Burixafor, anti-influenza drug TG-1000 and anti-hapatitis C virus drug Furaprevir. The company was founded on September 15, 2005 and is headquartered in Taipei, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4157 is 10.90 TWD — it hasn't changed in the past 24 hours. Watch TAIGEN BIOPHARMACEUTICALS HLDGS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange TAIGEN BIOPHARMACEUTICALS HLDGS LTD stocks are traded under the ticker 4157.
4157 stock has fallen by −7.63% compared to the previous week, the month change is a −12.80% fall, over the last year TAIGEN BIOPHARMACEUTICALS HLDGS LTD has showed a −29.68% decrease.
4157 reached its all-time high on Aug 30, 2013 with the price of 139.60 TWD, and its all-time low was 8.20 TWD and was reached on Mar 26, 2020. View more price dynamics on 4157 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4157 stock is 2.29% volatile and has beta coefficient of −0.04. Track TAIGEN BIOPHARMACEUTICALS HLDGS LTD stock price on the chart and check out the list of the most volatile stocks — is TAIGEN BIOPHARMACEUTICALS HLDGS LTD there?
Today TAIGEN BIOPHARMACEUTICALS HLDGS LTD has the market capitalization of 7.82 B, it has decreased by −5.06% over the last week.
Yes, you can track TAIGEN BIOPHARMACEUTICALS HLDGS LTD financials in yearly and quarterly reports right on TradingView.
TAIGEN BIOPHARMACEUTICALS HLDGS LTD is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
4157 net income for the last quarter is −71.97 M TWD, while the quarter before that showed 64.21 M TWD of net income which accounts for −212.09% change. Track more TAIGEN BIOPHARMACEUTICALS HLDGS LTD financial stats to get the full picture.
No, 4157 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 51.00 employees. See our rating of the largest employees — is TAIGEN BIOPHARMACEUTICALS HLDGS LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TAIGEN BIOPHARMACEUTICALS HLDGS LTD EBITDA is −128.17 M TWD, and current EBITDA margin is −119.46%. See more stats in TAIGEN BIOPHARMACEUTICALS HLDGS LTD financial statements.
Like other stocks, 4157 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TAIGEN BIOPHARMACEUTICALS HLDGS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TAIGEN BIOPHARMACEUTICALS HLDGS LTD technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TAIGEN BIOPHARMACEUTICALS HLDGS LTD stock shows the strong sell signal. See more of TAIGEN BIOPHARMACEUTICALS HLDGS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.